Brain-immune interactions and ischemic stroke: Clinical implications

Archives of Neurology

Volumn 69, Issue 5, 2012, Pages 576-581

  Kamel, Hooman ^a   Iadecola, Costantino ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN ANTIGEN; C REACTIVE PROTEIN; CATECHOLAMINE DERIVATIVE; CELL ADHESION MOLECULE; FIBRINOGEN; GLUCOCORTICOID; HEPARINOID; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; MYELIN; NITRIC OXIDE; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; STEROID; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CELL COUNT; CENTRAL NERVOUS SYSTEM; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; PARENCHYMA; PHAGOCYTOSIS; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; T LYMPHOCYTE; THROMBOSIS; TISSUE REPAIR;

BRAIN; BRAIN ISCHEMIA; HUMANS; IMMUNE SYSTEM; RISK; STROKE;

EID: 84860907056     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.3590     Document Type: Review

References (10)

1. Kaptoge S, Di Angelantonio E, Lowe G, et al Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140.
2. Broderick JP, Bonomo JB, Kissela BM, et al. Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence. Stroke. 2011;42(9):2509-2514.
3. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009;373(9658):155-166.
4. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796-808.
5. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation. 2006;113(17):2105-2112.
6. Kleinschnitz C, Schwab N, Kraft P, et al. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood. 2010;115(18):3835-3842.
7. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease - systematic review and meta-analysis. Neurobiol Aging. 2009;30(3):337-352.
8. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience. 2009;158(3):1098-1111.
9. Dziedzic T, Slowik A, Pera J, Szczudlik A. β-Blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252(1):53-56. (Pubitemid 44909190)
10. van de Beek D, Wijdicks EF, Vermeij FH, et al. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol. 2009; 66(9):1076-1081.